Specifically in Alzheimer’s disease, impaired Ca2+ signaling in astrocytic endfeet and mislocalization of aquaporin-4 (AQP4) channels disrupt glymphatic clearance, thereby promoting amyloid-β accumulation and vascular dysfunction [19,22,33]. Here, AQP4 is linked to Alzheimer disease.